A researcher at the IU Indianapolis Fairbanks School of Public Health has identified a set of novel biomarkers that could significantly improve early detection of pancreatic cancer, a disease with a five-year survival rate of just 13%, the lowest among major cancers.
This article was originally published on MedicalXpress.com

